New

Europe Virology Market

2021

Europe Virology Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Diagnostic Test, Viral Infection Controlling Techniques, Antiviral Therapeutics, and Interferons), Application (Skin and Soft Tissue Infections, Respiratory Tract Infections, GI Tract Infections, Sexually Transmitted Diseases, Urinary Tract Infection, and Others), and End User (Hospitals, Diagnostic Laboratories, Pharmaceutical and Biotechnological Companies, and Research and Academic Institutes)

Publication Month: Nov 2021 | Report Code: TIPRE00025736 | No. of Pages: 202 | Category: Biotechnology | Status: Published

Market Insights

Europe Virology Market to Grow at a CAGR of 3.4% to reach US$ 1,521.97 million from 2021 to 2028

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!

The virology market in Europe is expected to grow from US$ 1,208.26 million in 2021 to US$ 1,521.97 million by 2028; it is estimated to grow at a CAGR of 3.4% from 2021 to 2028.

The UK, Germany, France, Italy, and Spain are major economies in Europe. Virology is among the significant sections of the healthcare system. It has an extensive application in vaccine development, diagnostics, treatment therapies, and others. The market players are constantly involved in product innovations and developments to sustain the competition in the market. They explore various scopes for product innovations.
For instance, for COVID-19, market players are investing significantly in the development of vaccines, testing kits, and other related products and services. Below are a few of the market developments related to the virology market:
  • In August 2021, the U.S. Food and Drug Administration (FDA) approved the first COVID-19 vaccine known as the Pfizer-BioNTech COVID-19 Vaccine. It will be marketed as ComiRNAty (Koe-mir’-na-tee). The vaccine is intended to prevent COVID-19 disease in individuals aged 16 years and above. It is also available under emergency use authorization (EUA).
  • In April 2021, CerTest Biotec launched its CE-marked COVID-19 diagnostic test for the BD MAX System.
  • In May 2020, Bio-Rad received FDA approval for emergency use authorization for the COVID-19 total antibody test.
  • In May 2020, Aalto Bio Reagents launched New Recombinant Eukaryotic SARS-CoV-2 S1-S2 Spike Proteins.

Thus, such active participation of the market players by product innovations and favourable governments support is expected to bolster the growth of the Europe virology market.

Emerging virus epidemics occur unexpectedly and demand rapid action to stop the disease from spreading. The most recent outbreak of COVID-19 worldwide highlights the need developing diagnostics, vaccines, and antiviral drugs on an urgent basis. As COVID-19 belongs to the coronavirus family, much research into MERS and the development of vaccines against it enabled the rapid advancement of vaccines against COVID-19. Therefore, developing prototype vaccines against potential viruses could greatly accelerate the development of vaccines against any emerging pandemic. For instance, Before COVID-19, The Coalition for Epidemic Preparedness Innovations (CEPI) had developed a robust portfolio of MERS vaccine candidates and invested more than US$140 million to MERS vaccine development, which later laid the groundwork for rapid response to COVID-19 and enabled rapid COVID-19 vaccine development, including the Oxford vaccine. Also, CEPI established a collaboration with the University of Oxford in 2018 to develop a vaccine against MERS using their ChadOx vaccine platform. CEPI provided additional funding to the University of Oxford to adapt this platform technology to develop a vaccine against COVID-19. To scale the manufacture of their COVID-19 vaccine candidate, the University of Oxford subsequently partnered with AstraZeneca, who committed to producing the vaccine on a non-profit basis during the pandemic. Therefore, the pandemic preparedness has helped launch vaccines in a short period, further emphasizing the need for more investment in emerging virus’s research. Europe has been investing in the research of emerging viruses for a long time. The Centre has contributed expertise to recent Ebola outbreaks and is now working on COVID-19. In addition, Vaccine approvals have raised hopes of eventually overcoming the pandemic. However, recent outbreaks and the emergence of new strains of the virus affect the economic outcomes, and a post-pandemic will require governments and the private sector to make long-lasting commitments to global epidemic and pandemic preparedness.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive virology market. The Europe virology market is expected to grow at a good CAGR during the forecast period.

Europe virology market

Get more information on this report :


Europe Virology Market Segmentation

Europe Virology Market – By Type

  • Diagnostic Test
    • DNA Virus Testing
    • RNA Virus Testing
    • Others
  • Viral Infection Controlling Techniques
    • Active Prophylaxis
    • Passive Prophylaxis
  • Antiviral Therapeutics
    • Virucidal Agents
    • Antiviral Agents
    • Immunomodulators
  • Interferons

Europe Virology Market – By Application

  • Skin and Soft Tissue Infections
  • Respiratory Tract Infections
  • GI Tract Infections
  • Sexually Transmitted Diseases
  • Urinary Tract Infections
  • Others

Europe Virology Market – By End User

  • Hospitals
  • Diagnostic Laboratories
  • Pharmaceutical and Biotechnological Companies
  • Research and Academic Institutes

Europe Virology Market- By Country

  • U.K.
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Europe

Europe Virology Market-Companies Mentioned

  • Abbott
  • AbbVie Inc.
  • F. HOFFMANN-LA ROCHE LTD.
  • Gilead Sciences, Inc.
  • GlaxoSmithKline Plc
  • Illumina, Inc.
  • Johnson and Johnson Services, Inc.
  • QIAGEN
  • Siemens AG
  • THERMO FISHER SCIENTIFIC INC.

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Europe Virology Market – By Type

1.3.2 Europe Virology Market – By Application

1.3.3 Europe Virology Market – By End User

1.3.4 Europe Virology Market– By Country

2. Europe Virology Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Europe Virology Market– Market Landscape

4.1 Overview

4.2 Europe PEST Analysis

4.3 Experts Opinion

5. Europe Virology Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Growing Prevalence of Viral Infectious Diseases

5.1.2 Increasing Product Launches

5.2 Market Restraints

5.2.1 Availability of Alternative Products and High Cost of Production of Products

5.3 Market Opportunities

5.3.1 Growth Potential in Several Economies

5.4 Future Trends

5.4.1 Continuous Demand for Cost-Effective Products

5.5 Impact Analysis

6. Virology Market– Europe Analysis

6.1 Europe Virology Market Revenue Forecast and Analysis

7. Europe Virology Market Analysis – By Type

7.1 Overview

7.2 Europe Virology Market Revenue Share, by Type (2021 and 2028)

7.3 Diagnostic Test

7.3.1 Overview

7.3.2 Diagnostic Test: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.3.2.1 Deoxyribonucleic Acid (DNA) Virus Testing

7.3.2.1.1 Overview

7.3.2.1.2 DNA Virus Testing: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.3.2.2 Ribonucleic Acid (RNA) Virus Testing

7.3.2.2.1 Overview

7.3.2.2.2 RNA Virus Testing: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.3.2.3 Others

7.3.2.3.1 Overview

7.3.2.3.2 Others: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.4 Viral Infection Controlling Techniques

7.4.1 Overview

7.4.2 Viral Infection Controlling Techniques: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.4.2.1 Active Prophylaxis

7.4.2.1.1 Overview

7.4.2.1.2 Active Prophylaxis: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.4.2.2 Passive Prophylaxis

7.4.2.2.1 Overview

7.4.2.2.2 Passive Prophylaxis: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.5 Antiviral Therapeutics

7.5.1 Overview

7.5.2 Antiviral Therapeutics: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.5.2.1 Virucidal Agents

7.5.2.1.1 Overview

7.5.2.1.2 Virucidal Agents: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.5.2.2 Antiviral Agents

7.5.2.2.1 Overview

7.5.2.2.2 Antiviral Agents: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.5.2.3 Immunomodulators

7.5.2.3.1 Overview

7.5.2.3.2 Immunomodulators: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.6 Interferons

7.6.1 Overview

7.6.2 Interferons: Virology Market – Revenue and Forecast to 2028 (US$ Million)

8. Europe Virology Market Analysis – By Application

8.1 Overview

8.2 Europe Virology Market, by Application 2021 & 2028 (%)

8.3 Skin and Soft Tissue Infections

8.3.1 Overview

8.3.2 Skin and Soft Tissue Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)

8.4 Respiratory Tract Infections

8.4.1 Overview

8.4.2 Respiratory Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)

8.5 GI Tract Infections

8.5.1 Overview

8.5.2 GI Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)

8.6 Sexually Transmitted Diseases

8.6.1 Overview

8.6.2 Sexually Transmitted Diseases: Virology Market – Revenue and Forecast to 2028 (US$ Million)

8.7 Urinary Tract Infections

8.7.1 Overview

8.7.2 Urinary Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)

8.8 Others

8.8.1 Overview

8.8.2 Others: Virology Market – Revenue and Forecast to 2028 (US$ Million)

9. Europe Virology Market Analysis – By End User

9.1 Overview

9.2 Europe Virology Market Revenue Share, by End User (2021 and 2028)

9.3 Hospitals

9.3.1 Overview

9.3.2 Hospitals: Virology Market – Revenue and Forecast to 2028 (US$ Million)

9.4 Diagnostic Laboratories

9.4.1 Overview

9.4.2 Diagnostic Laboratories: Virology Market – Revenue and Forecast to 2028 (US$ Million)

9.5 Pharmaceutical and Biotechnological Companies

9.5.1 Overview

9.5.2 Pharmaceutical and Biotechnological Companies: Virology Market – Revenue and Forecast to 2028 (US$ Million)

9.6 Research and Academic Institutes

9.6.1 Overview

9.6.2 Research and Academic Institutes: Virology Market – Revenue and Forecast to 2028 (US$ Million)

10. Europe Virology Market – Country Analysis

10.1.1 Europe Virology Market Revenue and Forecasts to 2028, By Country (%)

10.1.1.1 UK Virology Market Revenue and Forecasts to 2028 (US$ million)

10.1.1.1.1 UK Virology Market Revenue and Forecasts to 2028 (US$ million)

10.1.1.1.2 UK Virology Market Revenue and Forecasts to 2028, By Type (US$ million)

10.1.1.1.2.1 UK: Virology Market, by Diagnostic Test, 2019–2028 (USD Million)

10.1.1.1.2.2 UK: Virology Market, by Viral Infection Controlling Techniques, 2019–2028 (USD Million)

10.1.1.1.2.3 UK: Virology Market, by Antiviral Therapeutics, 2019–2028 (USD Million)

10.1.1.1.3 UK Virology Market Revenue and Forecasts to 2028, by Application (US$ million)

10.1.1.1.4 UK Virology Market Revenue and Forecasts to 2028, by End User (US$ million)

10.1.1.2 Germany Virology Market Revenue and Forecasts to 2028 (US$ million)

10.1.1.2.1 Germany Virology Market Revenue and Forecasts to 2028 (US$ million)

10.1.1.2.2 Germany Virology Market Revenue and Forecasts to 2028, By Type (US$ million)

10.1.1.2.2.1 Germany: Virology Market, by Diagnostic Test, 2019–2028 (USD Million)

10.1.1.2.2.2 Germany: Virology Market, by Viral Infection Controlling Techniques, 2019–2028 (USD Million)

10.1.1.2.2.3 Germany: Virology Market, by Antiviral Therapeutics, 2019–2028 (USD Million)

10.1.1.2.3 Germany Virology Market Revenue and Forecasts to 2028, by Application (US$ million)

10.1.1.2.4 Germany Virology Market Revenue and Forecasts to 2028, by End User (US$ million)

10.1.1.3 France Virology Market Revenue and Forecasts to 2028 (US$ million)

10.1.1.3.1 France Virology Market Revenue and Forecasts to 2028 (US$ million)

10.1.1.3.2 France Virology Market Revenue and Forecasts to 2028, By Type (US$ million)

10.1.1.3.2.1 France: Virology Market, by Diagnostic Test, 2019–2028 (USD Million)

10.1.1.3.2.2 France: Virology Market, by Viral Infection Controlling Techniques, 2019–2028 (USD Million)

10.1.1.3.2.3 France: Virology Market, by Antiviral Therapeutics, 2019–2028 (USD Million)

10.1.1.3.3 France Virology Market Revenue and Forecasts to 2028, by Application (US$ million)

10.1.1.3.4 France Virology Market Revenue and Forecasts to 2028, by End User (US$ million)

10.1.1.4 Italy Virology Market Revenue and Forecasts to 2028 (US$ million)

10.1.1.4.1 Italy Virology Market Revenue and Forecasts to 2028 (US$ million)

10.1.1.4.2 Italy Virology Market Revenue and Forecasts to 2028, By Type (US$ million)

10.1.1.4.2.1 Italy: Virology Market, by Diagnostic Test, 2019–2028 (USD Million)

10.1.1.4.2.2 Italy: Virology Market, by Viral Infection Controlling Techniques, 2019–2028 (USD Million)

10.1.1.4.2.3 Italy: Virology Market, by Antiviral Therapeutics, 2019–2028 (USD Million)

10.1.1.4.3 Italy Virology Market Revenue and Forecasts to 2028, by Application (US$ million)

10.1.1.4.4 Italy Virology Market Revenue and Forecasts to 2028, by End User (US$ million)

10.1.1.5 Spain Virology Market Revenue and Forecasts to 2028 (US$ million)

10.1.1.5.1 Spain Virology Market Revenue and Forecasts to 2028 (US$ million)

10.1.1.5.2 Spain Virology Market Revenue and Forecasts to 2028, By Type (US$ million)

10.1.1.5.2.1 Spain: Virology Market, by Diagnostic Test, 2019–2028 (USD Million)

10.1.1.5.2.2 Spain: Virology Market, by Viral Infection Controlling Techniques, 2019–2028 (USD Million)

10.1.1.5.2.3 Spain: Virology Market, by Antiviral Therapeutics, 2019–2028 (USD Million)

10.1.1.5.3 Spain Virology Market Revenue and Forecasts to 2028, by Application (US$ million)

10.1.1.5.4 Spain Virology Market Revenue and Forecasts to 2028, by End User (US$ million)

10.1.1.6 Rest of Europe Virology Market Revenue and Forecasts to 2028 (US$ million)

10.1.1.6.1 Rest of Europe Virology Market Revenue and Forecasts to 2028 (US$ million)

10.1.1.6.2 Rest of Europe Virology Market Revenue and Forecasts to 2028, By Type (US$ million)

10.1.1.6.2.1 Rest of Europe: Virology Market, by Diagnostic Test, 2019–2028 (USD Million)

10.1.1.6.2.2 Rest of Europe: Virology Market, by Viral Infection Controlling Techniques, 2019–2028 (USD Million)

10.1.1.6.2.3 Rest of Europe: Virology Market, by Antiviral Therapeutics, 2019–2028 (USD Million)

10.1.1.6.3 Rest of Europe Virology Market Revenue and Forecasts to 2028, by Application (US$ million)

10.1.1.6.4 Rest of Europe Virology Market Revenue and Forecasts to 2028, by End User (US$ million)

11. Impact of COVID-19 Pandemic on Europe Virology Market

11.1 Overview

12. Europe Virology Market–Industry Landscape

12.1 Overview

12.2 Organic Developments

12.2.1 Overview

12.3 Inorganic Developments

12.3.1 Overview

13. Company Profiles

13.1 Abbott

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 Johnson and Johnson Services, Inc.

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 F. HOFFMANN-LA ROCHE LTD.

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 THERMO FISHER SCIENTIFIC INC.

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 QIAGEN

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 Illumina, Inc.

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 Siemens AG

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 GlaxoSmithKline Plc

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

13.9 AbbVie Inc.

13.9.1 Key Facts

13.9.2 Business Description

13.9.3 Products and Services

13.9.4 Financial Overview

13.9.5 SWOT Analysis

13.9.6 Key Developments

13.10 Gilead Sciences, Inc.

13.10.1 Key Facts

13.10.2 Business Description

13.10.3 Products and Services

13.10.4 Financial Overview

13.10.5 SWOT Analysis

13.10.6 Key Developments

14. Appendix

14.1 About The Insight Partners

14.2 Glossary of Terms

LIST OF TABLES

Table 1. Europe Virology Market Revenue and Forecast to 2028 (US$ Million)

Table 2. UK Virology Market Revenue and Forecasts to 2028, By Type US$ million)

Table 3. UK Virology Market, by Diagnostic Test– Revenue and Forecast to 2028 (USD Million)

Table 4. UK Virology Market, by Viral Infection Controlling Techniques– Revenue and Forecast to 2028 (USD Million)

Table 5. UK Virology Market, by Antiviral Therapeutics– Revenue and Forecast to 2028 (USD Million)

Table 6. UK Virology Market Revenue and Forecasts to 2028, by Application US$ million)

Table 7. UK Virology Market Revenue and Forecasts to 2028, by End User US$ million)

Table 8. Germany Virology Market Revenue and Forecasts to 2028, By Type (US$ million)

Table 9. Germany Virology Market, by Diagnostic Test– Revenue and Forecast to 2028 (USD Million)

Table 10. Germany Virology Market, by Viral Infection Controlling Techniques– Revenue and Forecast to 2028 (USD Million)

Table 11. Germany Virology Market, by Antiviral Therapeutics– Revenue and Forecast to 2028 (USD Million)

Table 12. Germany Virology Market Revenue and Forecasts to 2028, by Application US$ million)

Table 13. Germany Virology Market Revenue and Forecasts to 2028, by End User US$ million)

Table 14. France Virology Market Revenue and Forecasts to 2028, By Type (US$ million)

Table 15. France Virology Market, by Diagnostic Test– Revenue and Forecast to 2028 (USD Million)

Table 16. France Virology Market, by Viral Infection Controlling Techniques– Revenue and Forecast to 2028 (USD Million)

Table 17. France Virology Market, by Antiviral Therapeutics– Revenue and Forecast to 2028 (USD Million)

Table 18. France Virology Market Revenue and Forecasts to 2028, by Application (US$ million)

Table 19. France Virology Market Revenue and Forecasts to 2028, by End User (US$ million)

Table 20. Italy Virology Market Revenue and Forecasts to 2028, By Type (US$ million)

Table 21. Italy Virology Market, by Diagnostic Test– Revenue and Forecast to 2028 (USD Million)

Table 22. Italy Virology Market, by Viral Infection Controlling Techniques– Revenue and Forecast to 2028 (USD Million)

Table 23. Italy Virology Market, by Antiviral Therapeutics– Revenue and Forecast to 2028 (USD Million)

Table 24. Italy Virology Market Revenue and Forecasts to 2028, by Application (US$ million)

Table 25. Italy Virology Market Revenue and Forecasts to 2028, by End User (US$ million)

Table 26. Spain Virology Market Revenue and Forecasts to 2028, By Type (US$ million)

Table 27. Spain Virology Market, by Diagnostic Test– Revenue and Forecast to 2028 (USD Million)

Table 28. North America Virology Market, by Viral Infection Controlling Techniques– Revenue and Forecast to 2028 (USD Million)

Table 29. Spain Virology Market, by Antiviral Therapeutics– Revenue and Forecast to 2028 (USD Million)

Table 30. Spain Virology Market, by Application – Revenue and Forecast to 2028 by Application (USD Million)

Table 31. Spain Virology Market, by End User – Revenue and Forecast to 2028 by End User (USD Million)

Table 32. Rest of Europe Virology Market Revenue and Forecasts to 2028, By Type (US$ million)

Table 33. Rest of Europe Virology Market, by Diagnostic Test– Revenue and Forecast to 2028 (USD Million)

Table 34. Rest of Europe Virology Market, by Viral Infection Controlling Techniques– Revenue and Forecast to 2028 (USD Million)

Table 35. Rest of Europe Virology Market, by Antiviral Therapeutics– Revenue and Forecast to 2028 (USD Million)

Table 36. Rest of Europe Virology Market Revenue and Forecasts to 2028, by Application (US$ million)

Table 37. Rest of Europe Virology Market Revenue and Forecasts to 2028, by End User (US$ million)

Table 38. Organic Developments Done by Companies

Table 39. Inorganic Developments Done by Companies

Table 40. Glossary of Terms, Europe Virology Market

LIST OF FIGURES

Figure 1. Europe Virology Market Segmentation

Figure 2. Europe Virology Segmentation, By Country

Figure 3. Europe Virology Market Overview

Figure 4. Antiviral Therapeutics Held the Largest Share of the Type Segment in Europe Virology Market

Figure 5. Respiratory Tract Infections Held the Largest Share of the Application Segment in Europe Virology Market

Figure 6. UK to Show Significant Growth During Forecast Period

Figure 7. Europe and PEST Analysis

Figure 8. Europe Virology Market: Impact Analysis of Drivers and Restraints

Figure 9. Europe Virology Market– Revenue Forecast and Analysis – 2019- 2028

Figure 10. Europe Virology Market Revenue Share, by Type (2021 and 2028)

Figure 11. Europe Diagnostic Test: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12. Europe DNA Virus Testing: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13. Europe RNA Virus Testing: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14. Europe Others: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15. Europe Viral Infection Controlling Techniques: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16. Europe Active Prophylaxis: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17. Europe Passive Prophylaxis: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18. Europe Antiviral Therapeutics : Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19. Europe Virucidal Agents: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20. Europe Antiviral Agents: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21. Europe Immunomodulators: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22. Europe Interferons: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23. Europe Virology Market, by Application 2021 & 2028 (%)

Figure 24. Europe Skin and Soft Tissue Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25. Europe Respiratory Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26. Europe GI Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27. Europe Sexually Transmitted Diseases: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 28. Europe Urinary Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 29. Europe Others: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 30. Europe Virology Market Revenue Share, by End User (2021 and 2028)

Figure 31. Europe Hospitals: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 32. Europe Diagnostic Laboratories: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 33. Europe Pharmaceutical and Biotechnological Companies: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 34. Europe Research and Academic Institutes: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 35. Europe: Virology Market Revenue Overview, by Country, 2021 (US$ MN)

Figure 36. Europe Virology Market Revenue and Forecasts to 2028, By Country (%)

Figure 37. UK Virology Market Revenue and Forecasts to 2028 (US$ million)

Figure 38. Germany Virology Products Market Revenue and Forecasts to 2028 (US$ million)

Figure 39. France Virology Market Revenue and Forecasts to 2028 (US$ million)

Figure 40. Italy Virology Market Revenue and Forecasts to 2028 (US$ million)

Figure 41. Spain Virology Market Revenue and Forecasts to 2028 (US$ million)

Figure 42. Rest of Europe Virology Market Revenue and Forecasts to 2028 (US$ million)

Figure 43. Impact of COVID-19 Pandemic on Virology Market in European Countries

  1. Abbott
  2. AbbVie Inc.
  3. F. Hoffmann-La Roche Ltd.
  4. Gilead Sciences, Inc.
  5. GlaxoSmithKline Plc
  6. Illumina, Inc.
  7. Johnson and Johnson Services, Inc.
  8. QIAGEN
  9. Siemens AG
  10. Thermo Fisher Scientific Inc.
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe Virology market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the Europe Virology market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the Virology market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution
TIPRE00025736
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.